What technical signals does Korea Bio-Gen (318000) have?

Korea Bio-Gen current technical signals: no active technical signal.

Is Korea Bio-Gen a cup-and-handle pattern?

No. Korea Bio-Gen has no valid cup-and-handle signal right now.

What are Korea Bio-Gen's financials and valuation?

Korea Bio-Gen's income statement, balance sheet and cash flow are free for the most recent 8 years; the full history is on Pro. PER/PBR, dividend yield and sector valuation bands are free.

Korea Bio-Gen

318000 · KOSDAQ

₩2,830+0.18%

2026-09-04 close

Korea Bio-Gen last closed at ₩2,830 (+0.18%) on 2026-09-04. Listed on KOSDAQ; price, financials and dividends update daily after market close.

Loading chart…

No active signal.

New high + volume — the real recordrecord · not a prediction

Last 30 sessions

303 picks

Next-day win rate

50.7%

Avg next-day

-0.11%

vs market

-0.49%p

Every new-high-plus-volume pick we actually published (Korea market) — not this stock alone.

Trade plan

EntryAccount sizeStopTarget (optional)Risk per trade (%)

Fill entry, stop, account size and risk percent to get a share count. The stop must sit below the entry.

A calculator · not advice or a guarantee

Financials & valuation at a glance

B-

Overall: 화학 59/109 · top 54%

Factor composite · relative position in sector

PER 6.57 · PBR 0.55 — own-history percentile 100/100 · 100/100

Open self-history band

PER100/100

PBR100/100

Factual information · not investment advice

Past reported results · not investment advice

More — deeper indicators

Annual dividend

Split-adjusted annual DPS history and available grade axes

Annual dividend (per share · split-adjusted) · as of 2025

Consistency

B-

Growth

Yield

Safety

Reference indicatorView observed cut rates

Paid 6 consecutive years · Raised 0 consecutive years · Yield 2.65% (based on 2025 payment of 75원) · 3-year growth -9.1%

Per-share amount adjusted for splits and capital reductions · Factual information, not investment advice.

Financial safety

Reference indicatorAs of 2024

Safe zoneFinancial-metric reference signal

Altman Z'' zoneZ'' 11.83

Distress

Grey

Safe

The marker shows the current Z'' value within the displayed zones.

Altman Z'': 11.83
Beneish M-Score: -2.44
Sloan accrual: -1.01%

부실·조작 위험을 나타내는 사실 지표입니다. 투자 조언이 아니며, 검증 전이라 참고용입니다.

Factual information, not investment advice.

Earnings quality · Piotroski F-Score

5/9Moderate

Piotroski measures year-over-year financial improvement, not absolute quality.

Financial improvement score5/9

Profitability

Positive ROAPass
Positive OCFPass
Improving ΔROANot passed
Accruals (OCF > net income)Pass

Leverage & liquidity

Lower debtNot passed
Higher current ratioNot passed
No new sharesPass

Efficiency

Higher gross marginNot passed
Higher asset turnoverPass

Calculation note: F7(신주)은 equity/asset 유지로 근사

Already-stable companies may score lower when year-over-year improvement is limited.

Factual information, not investment advice.

Industry structure

KRAs of 2026-09-05

화학

This stock is in 화학: revenue rank 102 of 108, share 0%.

102 / 1080%revenue share

Who dominates this industry?

1LG화학31.9%
2롯데케미칼13.3%
3금호석유화학4.7%
4DL3.7%
5코오롱인더3.2%
6KBG0%

Concentration

DistributedCR3 49.9%

HHI 1,299108 revenue members

HHI and CR3 are separate industrial-organization facts; they are not the polarization verdict.

Polarization

MixedConsistent

Polarization measures industry gaps and structure, not valuation, forecast, or investment advice.

Margin lens

IQR%p: 8.84
Direction: 확대
Level: 보통
Years: 6

Value lens

P90/P10: 9.5
Median P/B: 0.68
Level: 넓음
n: 96

Survivorship note: 현재 산업 멤버십을 과거 연도에 소급 적용 — 과거 진입·퇴출 기업 미반영(복원 불가)

Factual information, not investment advice.

Risk sensitivity — adverse assumptions

Metric changes under stated assumptions; not a forecast or investment advice.

Base metrics

Operating margin: 16.1%
Interest coverage: 631.6x
Return on equity (ROE): 8.4%

Operating margin −5pp

Tolerable

Interest coverageBase 631.6x436x

Return on equity (ROE)Base 8.4%6.2%

Revenue −15%

Tolerable

Interest coverageBase 631.6x536.9x

Return on equity (ROE)Base 8.4%7.6%

Interest rate +2pp

Tolerable

Interest coverageBase 631.6x28.5x

Return on equity (ROE)Base 8.4%8.6%

Interest coverage limit

Current margin 16.1pp

Interest coverage limit at an operating margin of 0%

Interest expense coverage threshold

Who held it · filings

Filed record

A historical record from curated-guru 13F filings and DART 5%+ major-holding disclosures.

US 13F는 분기 공시이며 최대 45일 뒤 제출될 수 있습니다.

5%+ major-holding disclosures

부태웅35.95%2024-12-23 · 증감 0.00%p

Connections

AI-extracted related companies · for reference

Customers

LG화학Price comovement r=0.47 (1 year)에코프로비엠Price comovement r=0.44 (1 year)포스코퓨처엠Price comovement r=0.43 (1 year)삼성SDIPrice comovement r=0.41 (1 year)SK온LG에너지솔루션Price comovement r=0.40 (1 year)

Competitors

동화기업Price comovement r=0.37 (1 year)천보Price comovement r=0.52 (1 year)

Same theme

포스코홀딩스에코프로Price comovement r=0.45 (1 year)

🔗 See in the full market map →

Recent filings

Korea Bio-Gen's latest filings on Korea's DART. Open a headline for a reference summary and the original.

Source: DART (Korea electronic disclosure)

About Korea Bio-Gen

What technical signals does Korea Bio-Gen (318000) have?: Korea Bio-Gen current technical signals: no active technical signal.
Is Korea Bio-Gen a cup-and-handle pattern?: No. Korea Bio-Gen has no valid cup-and-handle signal right now.
What are Korea Bio-Gen's financials and valuation?: Korea Bio-Gen's income statement, balance sheet and cash flow are free for the most recent 8 years; the full history is on Pro. PER/PBR, dividend yield and sector valuation bands are free.

Like these rules? Backtest them.

Run this signal on this ticker in the free backtest builder — same window, no install.

Backtest this rule ↗

Quantus Signal · live data · not investment advice · Privacy Policy